Literature DB >> 15262337

Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration.

R G Thorne1, G J Pronk, V Padmanabhan, W H Frey.   

Abstract

We investigated the CNS delivery of insulin-like growth factor-I (IGF-I), a 7.65 kDa protein neurotrophic factor, following intranasal administration and the possible pathways and mechanisms underlying transport from the nasal passages to the CNS. Anesthetized adult male Sprague-Dawley rats were given [125I]-IGF-I intranasally or intravenously and then killed by perfusion-fixation within 30 min. Other animals were killed following cisternal puncture and withdrawal of cerebrospinal fluid (CSF) or intranasal administration of unlabeled IGF-I or vehicle. Both gamma counting of microdissected tissue and high resolution phosphor imaging of tissue sections showed that the tissue concentrations and distribution following intranasal administration were consistent with two routes of rapid entry into the CNS: one associated with the peripheral olfactory system connecting the nasal passages with the olfactory bulbs and rostral brain regions (e.g. anterior olfactory nucleus and frontal cortex) and the other associated with the peripheral trigeminal system connecting the nasal passages with brainstem and spinal cord regions. Intranasal administration of [125I]-IGF-I also targeted the deep cervical lymph nodes, consistent with their possible role in lymphatic drainage of both the nasal passages and the CNS. Cisternal CSF did not contain [125I]-IGF-I following intranasal administration. Intravenous [125I]-IGF-I resulted in blood and peripheral tissue exposure similar to that seen following intranasal administration but CNS concentrations were significantly lower. Finally, delivery of IGF-I into the CNS activated IGF-I signaling pathways, confirming some portion of the IGF-I that reached CNS target sites was functionally intact. The results suggest intranasally delivered IGF-I can bypass the blood-brain barrier via olfactory- and trigeminal-associated extracellular pathways to rapidly elicit biological effects at multiple sites within the brain and spinal cord.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15262337     DOI: 10.1016/j.neuroscience.2004.05.029

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  272 in total

1.  Nose-to-brain transport pathways of wheat germ agglutinin conjugated PEG-PLA nanoparticles.

Authors:  Qingfeng Liu; Yehong Shen; Jie Chen; Xiaoling Gao; Chengcheng Feng; Lu Wang; Qizhi Zhang; Xinguo Jiang
Journal:  Pharm Res       Date:  2011-12-14       Impact factor: 4.200

2.  Intranasal administration of PACAP: uptake by brain and regional brain targeting with cyclodextrins.

Authors:  Naoko Nonaka; Susan A Farr; Tomoya Nakamachi; John E Morley; Masanori Nakamura; Seiji Shioda; William A Banks
Journal:  Peptides       Date:  2012-06-09       Impact factor: 3.750

3.  Trigeminal pathways deliver a low molecular weight drug from the nose to the brain and orofacial structures.

Authors:  Neil J Johnson; Leah R Hanson; William H Frey
Journal:  Mol Pharm       Date:  2010-06-07       Impact factor: 4.939

Review 4.  The promise and pitfalls of intranasally administering psychopharmacological agents for the treatment of psychiatric disorders.

Authors:  D S Quintana; A J Guastella; L T Westlye; O A Andreassen
Journal:  Mol Psychiatry       Date:  2015-11-10       Impact factor: 15.992

Review 5.  The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders.

Authors:  Jesse Costales; Alexander Kolevzon
Journal:  Neurosci Biobehav Rev       Date:  2016-01-15       Impact factor: 8.989

6.  Intranasal delivery of obidoxime to the brain prevents mortality and CNS damage from organophosphate poisoning.

Authors:  Jishnu K S Krishnan; Peethambaran Arun; Abhilash P Appu; Nivetha Vijayakumar; Taíza H Figueiredo; Maria F M Braga; Sudikshya Baskota; Cara H Olsen; Natalia Farkas; John Dagata; William H Frey; John R Moffett; Aryan M A Namboodiri
Journal:  Neurotoxicology       Date:  2016-01-02       Impact factor: 4.294

7.  Intranasally administered neuropeptide S (NPS) exerts anxiolytic effects following internalization into NPS receptor-expressing neurons.

Authors:  Irina A Ionescu; Julien Dine; Yi-Chun Yen; Dominik R Buell; Leonie Herrmann; Florian Holsboer; Matthias Eder; Rainer Landgraf; Ulrike Schmidt
Journal:  Neuropsychopharmacology       Date:  2012-01-25       Impact factor: 7.853

Review 8.  Silence of the transcripts: RNA interference in medicine.

Authors:  Sailen Barik
Journal:  J Mol Med (Berl)       Date:  2005-07-19       Impact factor: 4.599

9.  Intranasal Delivery of a Caspase-1 Inhibitor in the Treatment of Global Cerebral Ischemia.

Authors:  Ningjun Zhao; Xiaoying Zhuo; Yujiao Lu; Yan Dong; Mohammad Ejaz Ahmed; Donovan Tucker; Erin L Scott; Quanguang Zhang
Journal:  Mol Neurobiol       Date:  2016-08-13       Impact factor: 5.590

Review 10.  Alzheimer's disease as homeostatic responses to age-related myelin breakdown.

Authors:  George Bartzokis
Journal:  Neurobiol Aging       Date:  2009-09-22       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.